7-氰基吲哚 | 96631-87-7

• 物质功能分类: 医药中间体 - 吲哚类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 7-氰基吲哚
• 中文别名: 7-氰基-1H-吲哚
• 英文名称: 7-cyanoindole
• 英文别名: 1H-indole-7-carbonitrile
• CAS: 96631-87-7
• 化学式: C₉H₆N₂
• mdl: MFCD00800653
• 分子量: 142.16
• InChiKey: NTUHBYLZRBVHRS-UHFFFAOYSA-N

物化性质

• 熔点：
  95-96 °C
• 沸点：
  350.0±15.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)
• 溶解度：
  氯仿（微溶）、甲醇（微溶）
• pKa：
  14.61±0.30 (Predicted,Most Acidic Temp: 25 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  39.6
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xn
• 危险类别码：
  R20/21/22
• 危险品运输编号：
  UN 3439
• 海关编码：
  2933990090
• 安全说明：
  S22,S36/37/39
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 7-Cyanoindole
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 7-Cyanoindole
CAS number: 96631-87-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H6N2
Molecular weight: 142.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  7-氰基吲哚 在 N-溴代丁二酰亚胺(NBS) 作用下， 以 四氢呋喃 为溶剂， 反应 16.0h， 以94%的产率得到3-bromo-1H-indole-7-carbonitrile
  参考文献：
  名称：

  [EN] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS
  [FR] COMPOSÉS INDOLIQUES UTILES EN TANT QUE MODULATEURS DU RÉCEPTEUR DES ANDROGÈNES

  摘要：

  本文提供了一种公式（V）的化合物，它们与雄激素受体（AR）的BF3结合，可以调节AR以治疗肯尼迪病。

  公开号：

  WO2022020342A1
• 作为产物：
  描述：

  7-氰基吲哚啉 在 氧气 、 sodium t-butanolate 作用下， 以 二甲基亚砜 为溶剂， 60.0 ℃ 、101.33 kPa 条件下， 反应 4.0h， 以58%的产率得到7-氰基吲哚
  参考文献：
  名称：

  DMSO / t-BuONa / O2介导的饱和N-杂环的好氧脱氢。

  摘要：

  芳族N-杂环如喹啉，异喹啉和二氢吲哚是通过叔丁醇钠促进的DMSO溶液中饱和杂环的氧化脱氢而合成的。该反应在温和的反应条件下进行并且具有良好的官能团耐受性。机理研究表明，一种自由基途径涉及从底物的N–H键或α–C–H夺取二甲基自由基的氢以及随后氮或α-氨基烷基自由基的氧化。

  DOI：

  10.1021/acs.joc.9b03447
• 作为试剂：
  描述：

  7-氰基吲哚 、 [2]thienyl magnesium (1+); bromide 、 硫酸 在 sodium hydroxide 、 solution 、 oil 、 乙酸乙酯 、 碳 、 7-氰基吲哚 作用下， 以 四氢呋喃 、 甲苯 为溶剂， 反应 6.33h， 以1.2 g of crystallized product was obtained corresponding to a yield of 38 percent relative to 7-cyanoindole的产率得到7-(2-thiophenecarbonyl)-indole
  参考文献：
  名称：

  Process for the production of 7-acylindoles

  摘要：

  一种制备7-酰基吲哚的方法，其通式为：##STR1## 从式为：##STR2##的吲哚开始。在第一阶段中，将吲哚腈化成式为：##STR3##的7-氰基吲哚。然后在第二阶段中，催化脱氢7-氰基吲哚，使其成为式为：##STR4##的7-氰吲哚。最后，在第三阶段中，将式为R-Q V的有机金属化合物与7-氰吲哚酰化，得到终产品式为I的7-酰基吲哚。

  公开号：

  US05380857A1

文献信息

• Substituted Indole Compounds
  申请人：Schunk Stefan

  公开号：US20100222324A1

  公开（公告）日：2010-09-02

  Substituted indole compounds corresponding to the formula I: In which R 8 , R 9a , R 9b , R 10 , R 11 , R 200 , R 210 , A, D, T, q, s and t have defined meanings, processes for the preparation thereof, pharmaceutical compositions containing such compounds and the use of substituted indole compounds for the treatment or inhibition of pain and other conditions which are at least partly mediated by Bradykinin 1 receptors (B1R).

  将与下式I对应的吲哚化合物替代： 其中R8、R9a、R9b、R10、R11、R200、R210、A、D、T、q、s和t具有定义的含义，其制备方法，含有这种化合物的药物组合物以及用于治疗或抑制至少部分由Bradykinin 1受体（B1R）介导的疼痛和其他病症的替代吲哚化合物的用途。
• An Acid-Catalyzed Addition and Dehydration Sequence for the Synthesis of Heteroarylated Steroidal Dienes
  作者：Tanner L. Metz、Grace A. Lutovsky、Levi M. Stanley

  DOI：10.1021/acs.joc.7b03045

  日期：2018.2.2

  Additions of heteroarenes to hormone steroids containing an α,β-unsaturated ketone are reported. Additions of a range of electron-rich heteroarene nucleophiles, including indoles, a pyrrole, and a thiophene, to a variety of commercially available steroids and subsequent dehydration formed 3-heteroarylated steroidal dienes in up to 93% yield. This atom-economical reaction sequence occurs under mild

  据报道，杂芳烃添加到含有α，β-不饱和酮的激素类固醇上。将多种电子富集的杂芳烃亲核试剂（包括吲哚，吡咯和噻吩）添加到各种市售类固醇中，随后脱水以高达93％的收率形成了3-杂芳基化的类固醇二烯。这种原子经济的反应顺序是在三氟甲磺酸铋催化下，在温和的反应条件下发生的。
• Indolyne Experimental and Computational Studies: Synthetic Applications and Origins of Selectivities of Nucleophilic Additions
  作者：G-Yoon J. Im、Sarah M. Bronner、Adam E. Goetz、Robert S. Paton、Paul H.-Y. Cheong、K. N. Houk、Neil K. Garg

  DOI：10.1021/ja1086485

  日期：2010.12.22

  conditions, trapped by a variety of nucleophilic reagents, and used to access a number of novel substituted indoles. Nucleophilic addition reactions to indolynes proceed with varying degrees of regioselectivity; distortion energies control regioselectivity and provide a simple model to predict the regioselectivity in the nucleophilic additions to indolynes and other unsymmetrical arynes. This model

  4,5-、5,6- 和 6,7-吲哚炔前体的有效合成从商业上可获得的羟基吲哚衍生物开始已有报道。合成路线是通用的，并允许获得在吡咯环上保持未取代的吲哚炔前体。Indolynes 可以在温和的氟化物介导的条件下生成，被各种亲核试剂捕获，并用于获取许多新型取代的吲哚。吲哚的亲核加成反应具有不同程度的区域选择性；畸变能控制区域选择性，并提供一个简单的模型来预测吲哚和其他不对称芳烃的亲核加成中的区域选择性。该模型导致设计出具有增强的亲核区域选择性的取代 4,5-吲哚炔。
• Development and Demonstration of a Safer Protocol for the Synthesis of 5-Aryltetrazoles from Aryl Nitriles
  作者：Daniel S. Treitler、Simon Leung、Mark Lindrud

  DOI：10.1021/acs.oprd.7b00016

  日期：2017.3.17

  for a faster, safer protocol for the direct synthesis of 5-aryltetrazoles from aryl nitriles in the presence of sodium azide and an amine hydrochloride salt led to the discovery of a buffered system comprised of BnNH2, BnNH2·HCl, and NaN3. After optimization of reaction conditions and a thorough investigation of reaction safety, the procedure was demonstrated for the synthesis of several hundred grams

  在叠氮化钠和胺盐酸盐存在下，寻找一种从芳基腈直接合成5-芳基四唑的更快，更安全的方法，导致发现了由BnNH 2，BnNH 2 ·HCl和NaN组成的缓冲体系。3。的反应条件和反应安全彻查优化之后，该过程被证明为几百克4-氯-2-（2-合成ħ -四唑-5-基）苯酚。通过使用16种额外的芳基和杂芳基腈底物进行小规模反应筛查，确定了开发的反应条件的一般性。
• Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
  申请人：——

  公开号：US20030069245A1

  公开（公告）日：2003-04-10

  This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with indoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

  这项发明提供了具有药物和生物影响性质的化合物，它们的药物组合物和使用方法。具体而言，该发明涉及吲哚酮乙酰哌嗪衍生物。这些化合物具有独特的抗病毒活性，无论是单独使用还是与其他抗病毒药物、抗感染药物、免疫调节剂或HIV进入抑制剂结合使用。更具体地，本发明涉及HIV和艾滋病的治疗。